A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON)
Clinical trial NCT03992430 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03992430
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-13
- Primary completion
- 2026-10-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.